Openbookopenbook
Equity
Medirom Healthcare Technologies Inc(MRM)
USD --+0.00%
Reward53Moderate
Risk74High
📊75%Data
Thin 1% profit margin · Revenue down 7% YoY
MRM
+0.0 · +0.00%
USD · NASDAQ
Medirom Healthcare Technologies Inc | Consumer Cyclical
Profitless Growth
Market Cap:10.98M
ℹ️
Reward Rating
53
Moderate
Bottom 50% (model universe)
75% data coverage
ℹ️
Risk Rating
74
High
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on MRM to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: ¥5.12.

What is Medirom Healthcare Technologies Inc?

, together with its subsidiaries, provides holistic health services in Japan.

MRM · Verdict

Moderate reward · high risk

MRM's standout is growth; valuation and balance sheet weigh on the picture.

Based on 88% data coverage

MRM · Verdict

What’s working & what to watch

Strengths 1

  • Growth84/100

    Revenue +15.3% CAGR

Watchouts 4

  • Valuation7/100

    Weak vs peers

  • Balance sheet11/100

    Interest covered 2.0×

  • Cash flow25/100

    -23% free-cash-flow margin

  • Profitability31/100

    2% net margin · 53% ROE

Model-based scoring. For information only — not financial advice.

What is Medirom Healthcare Technologies Inc?

, together with its subsidiaries, provides holistic health services in Japan. It operates in three segments: Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty. The company is listed on the NASDAQ in USA, operating in the Consumer Cyclical sector, with a market capitalisation of 10.98M, and a P/E ratio of 3.6x.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Performance tied to macro conditions — sensitive to interest rate cycles.
💸 Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: Moderate (53)

The scoring profile indicates limited reward potential at this time, with growth and momentum offering the most support. Risk indicators are high — this profile reflects meaningful downside exposure.

For informational purposes only. Not financial advice.

Company Information
SectorConsumer Cyclical
Market Cap10.98M
P/E Ratio3.5641
Dividend YieldN/A
52 Week High3.5299
52 Week Low0.3403
Last AnnualDecember
IPO Date12/29/2020
IncorporatedUSA
Shares Outstanding8M
No. of Employees334
IndustryPersonal Services
ExchangeNASDAQ
Beta0.971
CurrencyUSD · Reports in JPY
Websitemedirom.co.jp
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.